Humabiologics Overview

  • Founded
  • 2018

  • Status
  • Private

  • Employees
  • 7

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $667K

  • Investors
  • 1

Humabiologics General Information


Developer of a regenerative medicine intended to address the gap between the gift of donated human tissues and researchers. The company's product offers its users human-derived biomaterials to innovate regenerative medicine therapies, enabling them to address debilitating diseases and improve the quality of life for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Primary Office
  • 275 North Gateway Drive
  • Phoenix, AZ 85034
  • United States
+1 (602) 000-0000

Humabiologics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Humabiologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 04-Jan-2022 $667K 00.000 000.00 Completed Generating Revenue
2. Seed Round 08-Jun-2020 00.000 00.000 000 Completed Generating Revenue
1. Grant 27-Feb-2020 $30K Completed Generating Revenue
To view Humabiologics’s complete valuation and funding history, request access »

Humabiologics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Humabiologics’s complete cap table history, request access »

Humabiologics Executive Team (2)

Name Title Board Seat Contact Info
Mohammad Albanna Founder, Chief Executive Officer & Board Member
Daniel Mahaffey Chief Compliance Officer
To view Humabiologics’s complete executive team members history, request access »

Humabiologics Board Members (1)

Name Representing Role Since
Mohammad Albanna Humabiologics Founder, Chief Executive Officer & Board Member 000 0000
To view Humabiologics’s complete board members history, request access »

Humabiologics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Humabiologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AZBio Other 000 0000 000000 0
To view Humabiologics’s complete investors history, request access »